Physician profile
Mark George Carmichael
NPI 1811973043
$32,228.86
in general payments reported to CMS, 2019-2025
100 companies · $5,877 in 2025
The $5,877 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,309 · 2020: $2,928 · 2021: $4,117 · 2022: $5,677 · 2023: $5,395 · 2024: $4,927 · 2025: $5,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Education: $36.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,161.60 |
| Education | $36.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,015.84 | 2019-2025 | |
| Janssen Biotech, INC. | $1,833.14 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $1,659.52 | 2019-2025 | Imfinzi, Enhertu, Lynparza |
| Merck Sharp & Dohme LLC | $1,505.16 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $1,396.77 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,316.20 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Amgen INC. | $1,131.43 | 2019-2023 | Prolia, Evenity, Blincyto |
| Daiichi Sankyo INC. | $1,049.25 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Incyte Corporation | $877.95 | 2019-2025 | Jakafi, Monjuvi |
| Celgene Corporation | $870.88 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Abbvie INC. | $863.79 | 2019-2025 | Venclexta |
| E.R. Squibb & Sons, L.L.C. | $833.00 | 2019-2025 | Opdivo, Reblozyl |
| Regeneron Healthcare Solutions, INC. | $785.61 | 2019-2025 | Libtayo |
| Seagen INC. | $723.87 | 2019-2023 | Adcetris, Tivdak, Padcev |
| Gilead Sciences, INC. | $686.66 | 2021-2025 | Trodelvy |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $673.10 | 2019-2025 | Polivy, Phesgo, Tecentriq |
| Astellas Pharma US INC | $656.82 | 2019-2025 | Xtandi, Xospata, Vyloy |
| Eisai INC. | $629.49 | 2019-2025 | |
| Genzyme Corporation | $558.18 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $556.88 | 2020-2025 | Xpovio |
| Takeda Pharmaceuticals U.S.A., INC. | $539.39 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Pharmacyclics LLC, An Abbvie Company | $513.50 | 2019-2023 | Imbruvica, Epkinly |
| Blueprint Medicines Corporation | $457.81 | 2020-2025 | Ayvakit |
| Coherus Oncology, INC. | $389.75 | 2020-2025 | Loqtorzi |
| Ipsen Biopharmaceuticals, INC | $386.50 | 2021-2025 | Onivyde, Tazverik, Somatuline Depot |
| Puma Biotechnology, INC. | $383.13 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $374.68 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $364.87 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Dendreon Pharmaceuticals LLC | $361.32 | 2019-2025 | Provenge |
| Tersera Therapeutics LLC | $351.58 | 2019-2025 | Quzyttir, Xermelo |
| Galvanize Therapeutics, INC | $293.07 | 2023-2025 | Aliya System |
| Sobi, INC | $290.82 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.80 | 2020-2025 | Gilotrif |
| Lilly USA, LLC | $264.92 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Kite Pharma, INC. | $260.38 | 2019-2025 | Yescarta |
| Genmab U.S., INC. | $249.70 | 2024-2025 | Epkinly |
| Beone Medicines USA, INC. | $249.39 | 2025 | Tevimbra, Brukinsa |
| Emd Serono, INC. | $228.87 | 2019-2025 | Bavencio |
| Foundation Medicine, INC. | $221.44 | 2019-2023 | |
| Array Biopharma INC | $219.89 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Jazz Pharmaceuticals INC. | $193.83 | 2019-2025 | Vyxeos |
| Stemline Therapeutics INC. | $169.32 | 2023-2025 | Orserdu |
| Alexion Pharmaceuticals, INC. | $154.56 | 2020-2025 | Ultomiris |
| Csl Behring | $148.81 | 2019-2024 | Afstyla, Idelvion |
| Sun Pharmaceutical Industries INC. | $148.22 | 2020-2025 | Yonsa, Odomzo |
| Aveo Pharmaceuticals, INC. | $142.34 | 2022-2025 | Fotivda |
| Abbott Laboratories | $133.84 | 2019 | |
| Deciphera Pharmaceuticals INC. | $128.49 | 2021-2024 | Qinlock |
| Beigene USA, INC. | $128.16 | 2020-2022 | |
| Pharmaessentia USA Corporation | $126.98 | 2022-2025 | Besremi |
| Epizyme, INC. | $123.16 | 2021 | |
| Morphosys, US INC. | $122.97 | 2021-2023 | Monjuvi |
| Aurobindo Pharma USA, INC. | $119.42 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $115.87 | 2019-2022 | |
| Dova Pharmaceuticals | $112.09 | 2019-2021 | |
| Taiho Oncology, INC. | $109.89 | 2019-2025 | |
| Tempus Ai, INC | $103.72 | 2024 | |
| Agios Pharmaceuticals, INC. | $103.21 | 2020-2025 | Pyrukynd |
| Medtronic Vascular, INC. | $100.42 | 2020 | |
| Biogen, INC. | $96.72 | 2021 | |
| Servier Pharmaceuticals LLC | $95.94 | 2022-2025 | |
| Mirati Therapeutics, INC. | $95.61 | 2023-2024 | Krazati |
| Pharmacosmos Therapeutics INC. | $92.43 | 2022-2025 | Monoferric |
| Alnylam Pharmaceuticals INC. | $89.11 | 2021-2025 | Oxlumo, Givlaari |
| Immunocore Limited | $88.14 | 2023 | Kimmtrak |
| Spectrum Pharmaceuticals INC. | $87.32 | 2019-2025 | Rolvedon |
| Recordati_rare_diseases_inc. | $81.73 | 2023-2025 | Sylvant |
| Octapharma USA, INC. | $75.59 | 2019-2024 | Octagam Immune Globulin (Human) |
| Verity Pharmaceuticals INC. | $72.18 | 2023 | Trelstar |
| Kyowa Kirin, INC. | $71.44 | 2020-2025 | Poteligeo |
| Eusa Pharma (US) LLC | $68.42 | 2020-2022 | |
| Acceleron Pharma, INC. | $66.14 | 2020-2021 | |
| Ge Healthcare | $64.02 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $60.72 | 2019-2020 | |
| Iovance Biotherapeutics, INC. | $58.30 | 2025 | Amtagvi |
| Tg Therapeutics, INC. | $57.40 | 2021 | |
| Immunogen, INC. | $56.29 | 2023 | Elahere |
| Geron Corporation | $55.50 | 2025 | Rytelo |
| Adaptive Biotechnologies Corporation | $51.71 | 2022-2023 | Clonoseq |
| Sumitomo Pharma America, INC. | $51.27 | 2023-2025 | Orgovyx |
| Exelixis INC. | $47.88 | 2025 | Cabometyx |
| G1 Therapeutics, INC. | $47.19 | 2022 | |
| Acrotech Biopharma INC. | $45.46 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $45.18 | 2019 | |
| Azurity Pharmaceuticals, INC. | $42.35 | 2025 | Danziten, Vivimusta |
| Clovis Oncology, INC. | $42.16 | 2019-2020 | |
| Blue Earth Diagnostics | $39.08 | 2019-2023 | |
| Secura Bio, INC. | $35.52 | 2020 | |
| Adc Therapeutics America, INC. | $32.68 | 2025 | |
| Heron Therapeutics, INC. | $31.78 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $29.53 | 2019 | |
| Amneal Pharmaceuticals LLC | $28.00 | 2025 | Alymsys |
| Legend Biotech USA INC. | $26.66 | 2025 | Carvykti |
| Cti Biopharma Corp. | $26.00 | 2023 | Vonjo |
| Organon LLC | $25.86 | 2025 | Ontruzant |
| Fennec Pharmaceuticals, INC. | $25.77 | 2025 | Fyarro |
| Chiesi USA, INC. | $25.75 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $24.51 | 2022 | |
| Progenics Pharmaceuticals, INC. | $23.50 | 2022 | |
| Accord Healthcare, INC. | $22.81 | 2025 |
Drugs and devices associated with these payments
Keytruda $745Enhertu $627Libtayo $501Adcetris $427Kisqali $408Reblozyl $365Lynparza $362Epkinly $338Darzalex $334Lenvima $324Elrexfio $311Tecvayli $305Ayvakit $305Ojjaara $301Injectafer $294Aliya System $293Jakafi $272Welireg $266Imbruvica $255Rezlidhia $255Tavalisse $255Xpovio $254Provenge $245Doptelet $225Rybrevant $220Erleada $216Imfinzi $215Carvykti $209Scemblix $196Pluvicto $193Trodelvy $186Xtandi $186Nubeqa $184Talvey $182Venclexta $181Orserdu $169Onivyde $169Padcev $168Tukysa $168Yescarta $156Elahere $150Polivy $146Piqray $144Bosulif $136Zejula $135Jemperli $135Pomalyst $132Tevimbra $129Braftovi $126Mektovi $126Creon $124Orgovyx $121Brukinsa $120Fotivda $118Phesgo $115Ultomiris $113Ninlaro $112Lorbrena $112Jaypirca $111Verzenio $111Calquence $111Opdivo $108Tecentriq $105Fruzaqla $104Ibrance $103Balversa $102Akeega $102Tazverik $101Lunsumio $95.85Krazati $95.61Talzenna $94.30Inlyta $92.36Besremi $92.14Xalkori $90.66Lupron Depot $90.19Monjuvi $89.09Gilotrif $88.67Kimmtrak $88.14Xospata $88.04Tivdak $87.55Pyrukynd $86.23Gavreto $85.91Sarclisa $85.33Sylvant $81.73Alunbrig $79.91Nerlynx $78.12Qinlock $75.75Tibsovo $74.51Rolvedon $72.36Trelstar $72.18Tagrisso $71.72Somatuline Depot $71.17Evenity $71.15Prolia $71.15Monoferric $69.23Inqovi $68.14Lonsurf $68.14Afstyla $66.63Idelvion $66.63Perjeta $66.45
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.